2010
DOI: 10.4045/tidsskr.09.0689
|View full text |Cite
|
Sign up to set email alerts
|

Residiv og overlevelse etter kirurgisk behandling for lungekreft

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 16 publications
0
1
0
Order By: Relevance
“…Non-small cell lung cancer (NSCLC) has a poor prognosis, with a five-year survival rate of 40–50% in patients with pathological stage I or II disease who undergo a primary resection (24). Gender, age, type of surgery, tumor diameter and post-operative N-stage are significant contributing factors to the recurrence risk, with pathological stage and histological type significantly affecting recurrence-free survival (5,6)…”
Section: Introductionmentioning
confidence: 99%
“…Non-small cell lung cancer (NSCLC) has a poor prognosis, with a five-year survival rate of 40–50% in patients with pathological stage I or II disease who undergo a primary resection (24). Gender, age, type of surgery, tumor diameter and post-operative N-stage are significant contributing factors to the recurrence risk, with pathological stage and histological type significantly affecting recurrence-free survival (5,6)…”
Section: Introductionmentioning
confidence: 99%